Abstract:Background: Annonaceous acetogenins (ACGs) are secondary metabolites produced by the Annonaceae family and display potent anticancer activity against various cancer cell lines. Squamocin and bullatacin are two examples of ACGs that show promising antitumor activity; however, preclinical data are not sufficient partly due to their being highly lipophilic and poorly soluble in water. These compounds also display high toxicity to normal cells. Due to these disadvantageous properties, the therapeutic potential of squamocin and bullatacin as antitumor agents has not been fully evaluated. Methods: In order to enhance their water solubility and potentially improve their cancer targeting, squamocin and bullatacin were conjugated to a glucose or galactose to yield glycosylated derivatives by direct glycosylation or the Cu(I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition (CuAAC) reaction (the click reaction). The synthesized compounds were evaluated for their anticancer property against HeLa, A549 and HepG2 cancer cell lines using MTT assay. Results: Nine glycosyl derivatives were synthesized and structurally characterized. Most of them show comparable in vitro cytotoxicity against HeLa, A549 and HepG2 cancer cell lines as their parent compounds squamocin and bullatacin. It appears that the type of sugar residue (glucose or galactose), the position at which the sugar residue is attached, and whether or not a linking spacer is present do not affect the potency of these derivatives much. The solubility of galactosylated squamocin 13 in phosphate buffer saline (PBS, pH = 7) is greatly improved (1.37 mg/mL) in comparison to squamocin (not detected in PBS). Conclusion: The conjugation of a glucose or galactose to squamocin and bullatacin yields glycosyl derivatives with similar level of anticancer activity in tested cell lines. Further studies are needed to demonstrate whether or not these compounds show reduced toxicity to normal cells and their therapeutic potential as antitumor agents.

Synthesis and potential antimetastatic activity of monovalent and divalent β-d-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-d-glucopyranosides

Synthesis and antitumor activities of 3-phenylpropyl β-D-glucopyranosides

Synthesis of Galactosyl and Lactosyl Derivatives As Potential Anti-Metastasis Compounds

Design, synthesis, and evaluation of novel galloyl pyrrolidine derivatives as potential anti-tumor agents.

Synthesis and In vitro anti-cancer Activity evaluation of Glucosamine Derivatives

Synthesis and anti-tumor activities of methyl 2-O-aryl-6-O-aryl'-D-glucopyranosides.

Syntheses and anti-cancer activities of glycosylated derivatives of diosgenin

Synthesis of RGD-aPEG-lactoside, a Potential Anti-metastasis Glycoconjugate

Synthesis and Anticancer Activities of Glycyrrhetinic Acid Derivatives.

Synthesis, Biological Evaluation and Docking Studies of (E)-3-Aryl-2-(3,4,5-trimethoxybenzoyl) Acrylonitrile Derivatives as Anticancer Agents

Synthesis and Cytotoxic Property of Annonaceous Acetogenin Glycoconjugates

Synthesis and Antitumor Activities of Glucan Derivatives

Synthesis and anti-shock activity of divalentβ-D-galactopyranosyl-(1→ 4)- β-D-glucopyranosides

Enzymatic Biosynthesis and Biological Evaluation of Novel 17-AAG Glucoside As Potential Anti-Cancer Agents.

Synthesis and the Antitumor Activity of Several Phenylpropanoids

Synthesis and Anti-Angiogenetic Activity Evaluation of N-(3-aryl Acryloyl)aminosaccharide Derivatives

Synthesis and biological evaluation of glaucocalyxin A derivatives as potential anticancer agents.

Synthesis and Study of Antitumor Activity of Artimisinin Glucoside

Synthesis and Biological Evaluation of Glyco-Ga Compounds As Anticancer Agents

Syntheses and Anti-Cancer Activity of CO-releasing Molecules with Targeting Galactose Receptors

Anti-tumor and anti-metastasis of water-soluble sulfated β-glucan derivatives from Saccharomyces cerevisiae